CB
Cage Bio develops targeted therapeutics for dermatological and immunological conditions using proprietary biomolecular technologies. Their products aim to reduce inflammation and improve skin health by addressing the underlying biological mechanisms of these disorders.
Updated 20 months ago
Funding
$7.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
PX
Funding rounds are not available yet.
Founders
Product
Features
- Cage Bio develops targeted therapeutics for dermatological and immunological conditions using proprietary biomolecular technologies. Their products aim to reduce inflammation and improve skin health by addressing the underlying biological mechanisms of these disorders.